By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

If you're too busy to keep monitoring your stock portfolio every other day, then investing in stocks that won't cause you a ...

President-elect Donald Trump has asked the Supreme Court to delay implementation of the law banning TikTok. Western officials say North Korean soldiers are dying in high numbers along the Ukrainian ...

Although Novo will still make a mind-blowing amount of money from its existing obesity drugs in the coming years (its ...

A specific class of anti-inflammatory drugs can help children avoid a debilitating complication of Crohn's disease, a new ...

The fight against obstructive sleep apnea (OSA) has taken a monumental leap forward. For the first time, the U.S. Food and ...

In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their ...

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...

As the year draws to a close, Wall Street is set to crown Eli Lilly (NYSE:LLY) among the best in Big Pharma, while Novo ...

Alzheimer's, addiction, cardiovascular diseases, kidney disorders, sleep apnoea, diabetes, obesity, and overweight.

The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 500.39% and ...